Congestive heart failure exercise stress testing: Difference between revisions
Jump to navigation
Jump to search
/* 2009 ACC/AHA Focused Update and 2005 Guidelines for the Diagnosis and Management of Chronic Heart Failure in the Adult (DO NOT EDIT) Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart As... |
|||
| Line 15: | Line 15: | ||
Exercise stress testing is useful in measuring the "functional capacity" of heart failure patients. It is also helpful to assess the efficacy of congestive heart failure treatment. | Exercise stress testing is useful in measuring the "functional capacity" of heart failure patients. It is also helpful to assess the efficacy of congestive heart failure treatment. | ||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ | | colspan="1" style="text-align:center; background:LemonChiffon"| [[ESC guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki> | | bgcolor="LemonChiffon"|<nowiki>"</nowiki> [[Cardiopulmonary exercise testing]] is recommended as a part of the evaluation for [[heart transplantation]] and /or [[mechanical circulatory support]]. ''([[ESC guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | ||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ESC guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>[[Cardiopulmonary exercise testing]] should be considered to optimize prescription of [[exercise]] training. ''([[ESC guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |- | ||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki> | | bgcolor="LemonChiffon"|<nowiki>"</nowiki> [[Cardiopulmonary exercise testing]] should be considered to identify the cause of unexplained [[dyspnea]] and/or [[exercise intolerance]].''([[ESC guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
|} | |} | ||
Revision as of 05:44, 10 February 2022
 |
Resident Survival Guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
Exercise stress testing with an assessment of oxygen consumption is useful in assessing the functional capacity of the heart failure patient. Angiography can exclude the presence of an ischemic basis for the disease, and cardiac catheterization can evaluate the hemodynamic basis of heart failure and the response to drug. Myocardial viability studies can determine whether hypocontractile myocardium is viable but just hibernating, and could therefore benefit from revascularization.
Exercise Stress Testing
Exercise stress testing is useful in measuring the "functional capacity" of heart failure patients. It is also helpful to assess the efficacy of congestive heart failure treatment.
| Class I |
| " Cardiopulmonary exercise testing is recommended as a part of the evaluation for heart transplantation and /or mechanical circulatory support. (Level of Evidence: C) " |
| Class IIa |
| "Cardiopulmonary exercise testing should be considered to optimize prescription of exercise training. (Level of Evidence: C) " |
| " Cardiopulmonary exercise testing should be considered to identify the cause of unexplained dyspnea and/or exercise intolerance.(Level of Evidence: C) " |